X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA JUBILANT LIFE SCIENCES SHASUN PHARMA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 123.9 19.6 630.6% View Chart
P/BV x 8.5 4.2 204.3% View Chart
Dividend Yield % 0.2 0.4 53.6%  

Financials

 SHASUN PHARMA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
JUBILANT LIFE SCIENCES
Mar-14
SHASUN PHARMA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs94187 50.4%   
Low Rs4665 70.0%   
Sales per share (Unadj.) Rs214.2364.3 58.8%  
Earnings per share (Unadj.) Rs5.36.8 77.9%  
Cash flow per share (Unadj.) Rs15.824.5 64.6%  
Dividends per share (Unadj.) Rs1.003.00 33.3%  
Dividend yield (eoy) %1.42.4 60.1%  
Book value per share (Unadj.) Rs53.3164.9 32.3%  
Shares outstanding (eoy) m56.62159.28 35.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.3 94.4%   
Avg P/E ratio x13.118.4 71.2%  
P/CF ratio (eoy) x4.45.1 85.9%  
Price / Book Value ratio x1.30.8 171.6%  
Dividend payout %18.743.8 42.8%   
Avg Mkt Cap Rs m3,95820,061 19.7%   
No. of employees `000NA6.2 0.0%   
Total wages/salary Rs m2,16411,052 19.6%   
Avg. sales/employee Rs ThNM9,383.0-  
Avg. wages/employee Rs ThNM1,786.9-  
Avg. net profit/employee Rs ThNM176.3-  
INCOME DATA
Net Sales Rs m12,12758,034 20.9%  
Other income Rs m229191 120.3%   
Total revenues Rs m12,35658,224 21.2%   
Gross profit Rs m1,0095,786 17.4%  
Depreciation Rs m5942,812 21.1%   
Interest Rs m4153,237 12.8%   
Profit before tax Rs m230-72 -318.6%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m-73696 -10.4%   
Profit after tax Rs m3021,090 27.7%  
Gross profit margin %8.310.0 83.5%  
Effective tax rate %-31.7-965.9 3.3%   
Net profit margin %2.51.9 132.6%  
BALANCE SHEET DATA
Current assets Rs m6,88429,280 23.5%   
Current liabilities Rs m8,45638,912 21.7%   
Net working cap to sales %-13.0-16.6 78.1%  
Current ratio x0.80.8 108.2%  
Inventory Days Days6284 73.0%  
Debtors Days Days10851 212.2%  
Net fixed assets Rs m4,97055,712 8.9%   
Share capital Rs m113155 73.3%   
"Free" reserves Rs m2,87520,968 13.7%   
Net worth Rs m3,02026,265 11.5%   
Long term debt Rs m1,81717,169 10.6%   
Total assets Rs m13,34788,606 15.1%  
Interest coverage x1.61.0 158.9%   
Debt to equity ratio x0.60.7 92.1%  
Sales to assets ratio x0.90.7 138.7%   
Return on assets %5.44.9 110.0%  
Return on equity %10.04.2 241.0%  
Return on capital %13.311.6 115.2%  
Exports to sales %46.437.8 122.7%   
Imports to sales %14.216.5 86.4%   
Exports (fob) Rs m5,62221,933 25.6%   
Imports (cif) Rs m1,7289,567 18.1%   
Fx inflow Rs m5,84322,004 26.6%   
Fx outflow Rs m2,17311,749 18.5%   
Net fx Rs m3,66910,255 35.8%   
CASH FLOW
From Operations Rs m3988,026 5.0%  
From Investments Rs m-1,635-1,744 93.7%  
From Financial Activity Rs m1,309-4,447 -29.4%  
Net Cashflow Rs m711,834 3.9%  

Share Holding

Indian Promoters % 39.2 45.6 86.0%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 3.6 8.7 41.4%  
FIIs % 17.6 21.2 83.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 21.1 187.7%  
Shareholders   20,750 23,815 87.1%  
Pledged promoter(s) holding % 12.3 15.9 77.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  NOVARTIS  PANACEA BIOTECH  

Compare SHASUN PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Share Markets in India End Flat; Dr Reddy's & Tata Steel Top Gainers(Closing)

Indian share markets continued to trade range bound in afternoon session with market participants awaiting the US Federal Reserve's policy statement.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

180,000%: The Returns That Could Have Been(The 5 Minute Wrapup)

Sep 7, 2017

For successful investing in small caps, it's important to know when not to press the panic button.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS